CNTX Context Therapeutics Inc.
Healthcare$2.63+1.15%ClosedMarket Cap: $241.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.74
P/S
0.00
EV/EBITDA
-4.34
DCF Value
$0.67
FCF Yield
-13.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-60.0%
ROA
-68.3%
ROIC
-82.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-9.3M | $-8.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-13.8M | $-13.0M | $— | — |
| FY null | $0.00 | NaN% | $-39.7M | $-36.1M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-10.6M | $-9.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.8M | $-8.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.5M | $-4.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.3M | $-3.3M | $— | — |
| FY null | $0.00 | NaN% | $-29.9M | $-26.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-18.7M | $-17.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.1M | $-2.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.8M | $-3.7M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-6.9M | $-6.8M | $-0.42 | — |